Literature DB >> 16564098

Human papillomavirus genotyping using a modified linear array detection protocol.

Matthew P Stevens1, Suzanne M Garland, Sepehr N Tabrizi.   

Abstract

A standardized PCR-based linear array genotyping assay has been developed (Roche Molecular Systems) allowing the concurrent typing of 37 human papillomavirus (HPV) types. A component of this assay, the PCR amplicon detection protocol, requires the use of a shaking water-bath incubator for amplicon/probe hybridization and subsequent stringent washing, which many laboratories may find cumbersome or simply not possess. In this study, the utility of a dry-air incubator in substitution of the recommended shaking water-bath for use in this assay was confirmed. DNA was extracted by AmpliLute method from 150 PreservCyt specimens collected from patients undergoing ablation treatment for histologically confirmed cervical abnormality. The DNA was amplified by PCR and amplicons detected by both standard and modified protocols, varying only by the method of incubation for DNA hybridization and stringent washing. Identical HPV-type profiles were generated in 149/150 (99.3%) of the specimens tested by both protocols, representing a near perfect level of concordance (kappa = 0.98). It was proposed that this modification would markedly simplify the detection process, reduce setup time and eliminate the potential for water spillover, thereby allowing more laboratories to adopt this method subsequent to in-house validation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564098     DOI: 10.1016/j.jviromet.2006.02.007

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  12 in total

1.  Effect of ThinPrep preparation on human papillomavirus detection and genotyping in rectal samples by PCR.

Authors:  Sepehr N Tabrizi; Matthew P Stevens; Marina T van Leeuwen; Claire M Vajdic; Leon P Botes; Gabriele Medley; Richard Hillman; Andrew Grulich; Suzanne M Garland
Journal:  J Clin Microbiol       Date:  2008-11-12       Impact factor: 5.948

2.  Validation of an automated detection platform for use with the roche linear array human papillomavirus genotyping test.

Authors:  Matthew P Stevens; Suzanne M Garland; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

3.  Improving oral human papillomavirus detection using toothbrush sampling in HIV-positive men who have sex with men.

Authors:  Jason J Ong; Tim Read; Marcus Chen; Sandra Walker; Matthew Law; Catriona Bradshaw; Suzanne M Garland; Sepehr N Tabrizi; Alyssa Cornall; Andrew Grulich; Jane Hocking; Christopher K Fairley
Journal:  J Clin Microbiol       Date:  2014-04-09       Impact factor: 5.948

4.  Human papillomavirus genotyping using archival vulval dysplastic or neoplastic biopsy tissues: comparison between the INNO-LiPA and linear array assays.

Authors:  Sarah E Tan; Suzanne M Garland; Alice R Rumbold; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

5.  Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening.

Authors:  Mario Poljak; Anja Ostrbenk; Katja Seme; Veronika Ucakar; Peter Hillemanns; Eda Vrtacnik Bokal; Nina Jancar; Irena Klavs
Journal:  J Clin Microbiol       Date:  2011-03-23       Impact factor: 5.948

6.  Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.

Authors:  Matthew P Stevens; Suzanne M Garland; Elice Rudland; Jeffrey Tan; Michael A Quinn; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2007-05-09       Impact factor: 5.948

7.  Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program.

Authors:  Suzanne M Garland; Julia M L Brotherton; John R Condon; Peter B McIntyre; Matthew P Stevens; David W Smith; Sepehr N Tabrizi
Journal:  BMC Med       Date:  2011-09-13       Impact factor: 8.775

8.  Investigating a cluster of vulvar cancer in young women: a cross-sectional study of genital human papillomavirus prevalence.

Authors:  Alice R Rumbold; Sarah E Tan; John R Condon; Debbie Taylor-Thomson; Maria Nickels; Sepehr N Tabrizi; Margaret L J Davy; Margaret M O'Brien; Christine M Connors; Ibrahim Zardawi; Jim Stankovich; Suzanne M Garland
Journal:  BMC Infect Dis       Date:  2012-10-05       Impact factor: 3.090

9.  Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study).

Authors:  Elisa J Young; Sepehr N Tabrizi; Julia Ml Brotherton; John D Wark; Jan Pyman; Marion Saville; C David Wrede; Yasmin Jayasinghe; Jeffrey Tan; Dorota M Gertig; Marian Pitts; Suzanne M Garland
Journal:  BMC Cancer       Date:  2013-06-19       Impact factor: 4.430

10.  A case-control study of the role of human papillomavirus in oesophageal squamous cell carcinoma in australia.

Authors:  Surabhi S Liyanage; Eva Segelov; Aisha Malik; Suzanne M Garland; Sepehr N Tabrizi; Eleanor Cummins; Holly Seale; Bayzidur Rahman; Aye Moa; Andrew P Barbour; Philip J Crowe; C Raina MacIntyre
Journal:  J Oncol       Date:  2014-04-28       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.